David Forman

Summary

Affiliation: International Agency for Research on Cancer
Country: France

Publications

  1. pmc Estimating and validating disability-adjusted life years at the global level: a methodological framework for cancer
    Isabelle Soerjomataram
    Department of Public Health, Erasmus MC, Rotterdam, The Netherlands
    BMC Med Res Methodol 12:125. 2012
  2. doi request reprint Global burden of human papillomavirus and related diseases
    David Forman
    Section of Cancer Information, International Agency for Research on Cancer, Lyon, France
    Vaccine 30:F12-23. 2012
  3. pmc Feasibility test of a UK-scalable electronic system for regular collection of patient-reported outcome measures and linkage with clinical cancer registry data: the electronic Patient-reported Outcomes from Cancer Survivors (ePOCS) system
    Laura Ashley
    Psychosocial Oncology and Clinical Practice Research Group, University of Leeds, St James s Institute of Oncology, Beckett Street, Leeds, LS9 7TF, UK
    BMC Med Inform Decis Mak 11:66. 2011
  4. pmc Multilevel latent class casemix modelling: a novel approach to accommodate patient casemix
    Mark S Gilthorpe
    Centre for Epidemiology and Biostatistics, School of Medicine, University of Leeds, Worsley Building, Clarendon Way, Leeds, LS2 9JT, UK
    BMC Health Serv Res 11:53. 2011
  5. pmc The epidemiology of bone cancer in 0 - 39 year olds in northern England, 1981 - 2002
    Rachel Eyre
    Institute of Health and Society, Newcastle University, Sir James Spence Institute, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP, England, UK
    BMC Cancer 10:357. 2010
  6. doi request reprint Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions
    Isabelle Soerjomataram
    Section of Cancer Information, International Agency for Research on Cancer, Lyon, France
    Lancet 380:1840-50. 2012
  7. doi request reprint Global burden of cancers attributable to infections in 2008: a review and synthetic analysis
    Catherine de Martel
    International Agency for Research on Cancer, Lyon, France
    Lancet Oncol 13:607-15. 2012
  8. doi request reprint Global cancer transitions according to the Human Development Index (2008-2030): a population-based study
    Freddie Bray
    Section of Cancer Information, International Agency for Research on Cancer, Lyon, France
    Lancet Oncol 13:790-801. 2012
  9. doi request reprint Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
    Jacques Ferlay
    Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France
    Int J Cancer 136:E359-86. 2015
  10. doi request reprint Global burden of gastric cancer attributable to Helicobacter pylori
    Martyn Plummer
    International Agency for Research on Cancer, Lyon, France
    Int J Cancer 136:487-90. 2015

Collaborators

Detail Information

Publications19

  1. pmc Estimating and validating disability-adjusted life years at the global level: a methodological framework for cancer
    Isabelle Soerjomataram
    Department of Public Health, Erasmus MC, Rotterdam, The Netherlands
    BMC Med Res Methodol 12:125. 2012
    ..The variables required to compute DALYs are however multiple and not readily available in many countries. We propose a methodology that derives global DALYs and validate variables and DALYs based on data from various cancer registries...
  2. doi request reprint Global burden of human papillomavirus and related diseases
    David Forman
    Section of Cancer Information, International Agency for Research on Cancer, Lyon, France
    Vaccine 30:F12-23. 2012
    ..1 to 0.2% with a peak occurring at teenage and young adult ages. This article forms part of a special supplement entitled "Comprehensive Control of HPV Infections and Related Diseases" Vaccine Volume 30, Supplement 5, 2012...
  3. pmc Feasibility test of a UK-scalable electronic system for regular collection of patient-reported outcome measures and linkage with clinical cancer registry data: the electronic Patient-reported Outcomes from Cancer Survivors (ePOCS) system
    Laura Ashley
    Psychosocial Oncology and Clinical Practice Research Group, University of Leeds, St James s Institute of Oncology, Beckett Street, Leeds, LS9 7TF, UK
    BMC Med Inform Decis Mak 11:66. 2011
    ..This study aims to test the feasibility of the ePOCS system, by running it for 2 years in two Yorkshire NHS Trusts, and using the Northern and Yorkshire Cancer Registry and Information Service...
  4. pmc Multilevel latent class casemix modelling: a novel approach to accommodate patient casemix
    Mark S Gilthorpe
    Centre for Epidemiology and Biostatistics, School of Medicine, University of Leeds, Worsley Building, Clarendon Way, Leeds, LS2 9JT, UK
    BMC Health Serv Res 11:53. 2011
    ..We contrast this with ranks derived from Trust standardised mortality ratios (SMRs)...
  5. pmc The epidemiology of bone cancer in 0 - 39 year olds in northern England, 1981 - 2002
    Rachel Eyre
    Institute of Health and Society, Newcastle University, Sir James Spence Institute, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP, England, UK
    BMC Cancer 10:357. 2010
    ..There is a paucity of recent epidemiological data on bone cancers. The aim of this study was to describe incidence and survival patterns for bone cancers diagnosed during 1981 - 2002...
  6. doi request reprint Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions
    Isabelle Soerjomataram
    Section of Cancer Information, International Agency for Research on Cancer, Lyon, France
    Lancet 380:1840-50. 2012
    ..Country comparisons that consider the effect of fatal and non-fatal disease outcomes are needed for health-care planning. We calculated disability-adjusted life-years (DALYs) to estimate the global burden of cancer in 2008...
  7. doi request reprint Global burden of cancers attributable to infections in 2008: a review and synthetic analysis
    Catherine de Martel
    International Agency for Research on Cancer, Lyon, France
    Lancet Oncol 13:607-15. 2012
    ..Infections with certain viruses, bacteria, and parasites have been identified as strong risk factors for specific cancers. An update of their respective contribution to the global burden of cancer is warranted...
  8. doi request reprint Global cancer transitions according to the Human Development Index (2008-2030): a population-based study
    Freddie Bray
    Section of Cancer Information, International Agency for Research on Cancer, Lyon, France
    Lancet Oncol 13:790-801. 2012
    ..Cancer is set to become a major cause of morbidity and mortality in the coming decades in every region of the world. We aimed to assess the changing patterns of cancer according to varying levels of human development...
  9. doi request reprint Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
    Jacques Ferlay
    Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France
    Int J Cancer 136:E359-86. 2015
    ..82 million), breast (1.67 million), and colorectal (1.36 million); the most common causes of cancer death were lung cancer (1.6 million deaths), liver cancer (745,000 deaths), and stomach cancer (723,000 deaths). ..
  10. doi request reprint Global burden of gastric cancer attributable to Helicobacter pylori
    Martyn Plummer
    International Agency for Research on Cancer, Lyon, France
    Int J Cancer 136:487-90. 2015
    ..pylori infection for a total of around 780,000 cases (6.2% instead of 5.2% of all cancers). These updated estimates reinforce the role of H. pylori as a major cause of cancer. ..
  11. doi request reprint Global incidence of oesophageal cancer by histological subtype in 2012
    Melina Arnold
    Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France
    Gut 64:381-7. 2015
    ..To date, global incidence estimates for individual subtypes are still lacking. This study for the first time quantified the global burden of oesophageal cancer by histological subtype...
  12. doi request reprint Helicobacter pylori eradication in the prevention of gastric cancer: are more trials needed?
    Jin Young Park
    Prevention and Implementation Group, Early Detection and Prevention Section, International Agency for Research on Cancer, 150 cours Albert Thomas, 69372, Lyon Cedex 08, France
    Curr Oncol Rep 15:517-25. 2013
    ..Appropriately designed studies will help address these issues and hasten the implementation of population-wide prevention programs. ..
  13. doi request reprint Gastric cancer: epidemiology and risk factors
    Catherine de Martel
    International Agency for Research on Cancer, Lyon, France
    Gastroenterol Clin North Am 42:219-40. 2013
    ..When the data and the literature allow, we distinguish between cardia and noncardia sub-sites, as it is now clear that these two anatomic locations present distinct and sometimes opposite epidemiological characteristics...
  14. doi request reprint Co-occurrence of diffuse large B cell non-hodgkin lymphoma and chronic hepatitis C in Algerian patients: two case reports
    Karima Chaabna
    Section of Cancer Information, International Agency for Research on Cancer, 150 Cours A, Thomas, Lyon Cedex, France
    J Cancer Res Ther 9:532-3. 2013
    ..Furthermore, our observations underscore the importance of prevention programmes including screening to control HCV in Algeria...
  15. doi request reprint Kaposi sarcoma trends in Uganda and Zimbabwe: a sustained decline in incidence?
    Karima Chaabna
    Section of Cancer Information, International Agency for Research on Cancer, Lyon, France
    Int J Cancer 133:1197-203. 2013
    ..The combined introduction of antiretroviral therapy and effective prevention programmes against HIV/AIDS appeared to be the key contributors to the KS decline observed in both Uganda and Zimbabwe. ..
  16. doi request reprint Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
    Jacques Ferlay
    Section of Cancer Information, International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
    Int J Cancer 127:2893-917. 2010
    ..7%) and liver cancer (696,000 deaths, 9.2%). Cancer is neither rare anywhere in the world, nor mainly confined to high-resource countries. Striking differences in the patterns of cancer from region to region are observed...
  17. doi request reprint The ban on phenacetin is associated with changes in the incidence trends of upper-urinary tract cancers in Australia
    Sebastien Antoni
    Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France
    Aust N Z J Public Health 38:455-8. 2014
    ..It was banned in most countries from the late 1960s. This study aimed to evaluate, for the first time, the long-term population impact of the phenacetin ban on UUT cancer rates...
  18. pmc Global burden of cancer attributable to high body-mass index in 2012: a population-based study
    Melina Arnold
    Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France Electronic address
    Lancet Oncol 16:36-46. 2015
    ..High body-mass index (BMI; defined as 25 kg/m(2) or greater) is associated with increased risk of cancer. To inform public health policy and future research, we estimated the global burden of cancer attributable to high BMI in 2012...
  19. pmc Cancer in indigenous people in Latin America and the Caribbean: a review
    Suzanne P Moore
    International Agency for Research on Cancer, Lyon, France
    Cancer Med 3:70-80. 2014
    ....